Buys
Open market- Shares
- +10,870
- Avg price
- $9.09
- Total value
- +$98,808
Matthias Bodenstedt - Chief Financial Officer at MoonLake Immunotherapeutics
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- MLTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Matthias Bodenstedt in MoonLake Immunotherapeutics
Sells
Open market- Shares
- -160,870
- Avg price
- $19.88
- Total value
- -$3,198,501
Net
Past year- Shares
- -150,000
- Share %
- -87%
- Total value
- -$3,099,693
Reported holdings for Matthias Bodenstedt in MoonLake Immunotherapeutics
Form 4 holding
Chief Financial Officer
MoonLake Immunotherapeutics
- Security class
- Class A ordinary shares, par value $0.0001 per share
- Shares / value
- 1,115,435
- Estimated value
- $24,584,187
- Report date
- 22 Jun 2026
- Price
- $22.04
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
MoonLake Immunotherapeutics
- Security class
- Class C ordinary shares, par value $0.0001 per share
- Shares / value
- 0
- Estimated value
- Report date
- 19 Dec 2025
- Price
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
MoonLake Immunotherapeutics
- Security class
- Common shares, par value CHF 0.10 per share, of MoonLake AG
- Shares / value
- 0
- Estimated value
- Report date
- 19 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Class A ordinary shares, par value $0.0001 per share
- Underlying amount
Transaction history for Matthias Bodenstedt in MoonLake Immunotherapeutics
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.